Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity

Oxygen toxicity, oxygen radicals, transition metals and disease

Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599

Copper, iron and zinc in Alzheimer's disease senile plaques

Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120

Hydrogen peroxide mediates amyloid β protein toxicity

Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074

Undetectable Intracellular Free Copper: The Requirement of a Copper Chaperone for Superoxide Dismutase

Rae, T., Schmidt, P. J., Pufahl, R. A., Culotta, V., & O’Halloran, T. V. (1999) · Science · doi:10.1126/science.284.5415.805 · Cited by 1,640

Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486

An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp 717 ) Mutants

Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471

The cellular prion protein binds copper in vivo

Brown, D. R., Qin, K., Herms, J., Madlung, A., Manson, J., Strome, R., Fraser, P., Kruck, T., von Bohlen, A., Schulz-Schaeffer, W., et al. (1997) · Nature · doi:10.1038/37783 · Cited by 1,300

The biological chemistry of the elements

(1993) · The Science of The Total Environment · doi:10.1016/0048-9697(93)90224-t · Cited by 1,173

Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals

Bagheri, S., Squitti, R., Haertlé, T., Siotto, M., & Saboury, A. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00446 · Cited by 235

Interactions of Zn(ii) and Cu(ii) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity

Tõugu, V., Tiiman, A., & Palumaa, P. (2011) · Metallomics · doi:10.1039/c0mt00073f · Cited by 224

Coordination abilities of the 1–16 and 1–28 fragments of β-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study

Kowalik‐Jankowska, T., Ruta, M., Wiśniewska, K., & Łankiewicz, L. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(03)00128-4 · Cited by 222

Metal Chelation as a Potential Therapy for Alzheimer's Disease

Cuajungco, M. P., Faget, K. Y., Huang, X., Tanzi, R. E., & Bush, A. I. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06938.x · Cited by 220

Amyloid peptides and proteins in review

Harrison, R. S., Sharpe, P. C., Singh, Y., & Fairlie, D. P. (2007) · Springer eBooks · doi:10.1007/112_2007_0701 · Cited by 222

Mechanisms of Copper Ion Mediated Huntington's Disease Progression

Fox, J. H., Kama, J. A., Lieberman, G., Chopra, R., Dorsey, K., Chopra, V., Volitakis, I., Cherny, R. A., Bush, A. I., & Hersch, S. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000334 · Cited by 220

Mysterious oligomerization of the amyloidogenic proteins

Uversky, V. N. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07721.x · Cited by 219

Binding of zinc(II) and copper(II) to the full‐length Alzheimer’s amyloid‐β peptide

Tõugu, V., Tiiman, A., & Palumaa, P. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05061.x · Cited by 219

Copper signaling in the mammalian nervous system: Synaptic effects

Gaier, E. D., Eipper, B. A., & Mains, R. E. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23143 · Cited by 210

Current Status of Metals as Therapeutic Targets in Alzheimer's Disease

Finefrock, A. E., Bush, A. I., & Doraiswamy, P. M. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51368.x · Cited by 203

Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide

Sharma, A. K., Pavlova, S. T., Kim, J., Finkelstein, D., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210588m · Cited by 202

Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical Relevance

Jiang, D., Men, L., Wang, J., Zhang, Y., Chickenyen, S., Wang, Y., & Zhou, F. (2007) · Biochemistry · doi:10.1021/bi700508n · Cited by 204

The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice

Lee, J., Friedman, J. E., Angel, I., Kozak, A., & Koh, J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.01.005 · Cited by 190

Metal swap between Zn7-metallothionein-3 and amyloid-β–Cu protects against amyloid-β toxicity

Meloni, G., Sonois, V., Delaine, T., Guilloreau, L., Gillet, A., Teissié, J., Faller, P., & Vašák, M. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.89 · Cited by 190

Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms

Rommy von Bernhardi, M., & Eugenín, J. L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4082 · Cited by 193

Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine Oxidation

Barnham, K. J., Ciccotosto, G. D., Tickler, A. K., Ali, F. E. A., Smith, D. G., Williamson, N. A., Lam, Y.-H., Carrington, D., Tew, D. J., Kocak, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305494200 · Cited by 191

The Amyloid-β Peptide of Alzheimer’s Disease Binds Cu I in a Linear Bis-His Coordination Environment: Insight into a Possible Neuroprotective Mechanism for the Amyloid-β Peptide

Shearer, J., & Szalai, V. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805940m · Cited by 191

In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP

Butterfield, D. A., Galván, V., Lange, M. L. B., Tang, H., Robinson, R. A. S., Spilman, P. R., Fombonne, J., Gorostiza, O. F., Zhang, J., Rukhsana Sultana, A., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.035 · Cited by 188

Copper-mediated Amyloid-β Toxicity Is Associated with an Intermolecular Histidine Bridge

Smith, D. P., Smith, D. G., Curtain, C. C., Boas, J. F., Pilbrow, J. R., Ciccotosto, G. D., Lau, T., Tew, D. J., Perez, K. A., Wade, J. D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600417200 · Cited by 186

Copper and Alzheimer's disease

Donnelly, P. S., Xiao, Z., & Wedd, A. G. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.01.678 · Cited by 188

Three Histidine Residues of Amyloid-β Peptide Control the Redox Activity of Copper and Iron

Nakamura, M., Shishido, N., Nunomura, A., Smith, M. A., Perry, G. L., Hayashi, Y., Nakayama, K., & Hayashi, T. (2007) · Biochemistry · doi:10.1021/bi701079z · Cited by 184

The Alzheimer’s therapeutic PBT2 promotes amyloid‐β degradation and GSK3 phosphorylation via a metal chaperone activity

Crouch, P. J., Savva, M. S., Hung, L. W., Donnelly, P. S., Mot, A. I., Parker, S. J., Greenough, M. A., Volitakis, I., Adlard, P. A., Cherny, R. A., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07402.x · Cited by 183

Nanomaterials for Reducing Amyloid Cytotoxicity

Zhang, M., Mao, X., Yu, Y., Wang, C.-X., Yang, Y., & Wang, C. (2013) · Advanced Materials · doi:10.1002/adma.201301210 · Cited by 183

A central role for dityrosine crosslinking of Amyloid-β in Alzheimer’s disease

Al‐Hilaly, Y. K., Williams, T. L., Stewart-Parker, M., Ford, L. K., Skaria, E., Cole, M., Bucher, W. G., Morris, K. L., Sada, A. A., Thorpe, J. R., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-83 · Cited by 187

Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases

Merelli, A., Repetto, M. G., Lazarowski, A., & Auzmendi, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201074 · Cited by 188

α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro

Turnbull, S., Tabner, B. J., El‐Agnaf, O. M. A., Moore, S., Davies, Y., & Allsop, D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00513-5 · Cited by 183

Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies

Bucossi, S., Ventriglia, M., Panetta, V., Salustri, C., Pasqualetti, P., Mariani, S., Siotto, M., Rossini, P. M., & Squitti, R. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101473 · Cited by 186

Zn(II)‐ and Cu(II)‐induced non‐fibrillar aggregates of amyloid‐β (1–42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators

Tõugu, V., Karafin, A., Zovo, K., Chung, R. S., Howells, C., West, A. K., & Palumaa, P. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06269.x · Cited by 181

Natural Antioxidants Protect Neurons in Alzheimer’s Disease and Parkinson’s Disease

Zhao, B. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9900-9 · Cited by 180

Metallothionein III is reduced in Alzheimer’s disease

Yu, W. H., Lukiw, W. J., Bergeron, C., Niznik, H. B., & Fraser, P. E. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03196-6 · Cited by 180

Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-β peptides involved in Alzheimer disease. Part 1: An overview

Hureau, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.037 · Cited by 183

Oxidative Stress Gated by Fenton and Haber Weiss Reactions and Its Association With Alzheimer’s Disease

Kanti Das, T., Wati, M. R., & Fatima-Shad, K. (2014) · Archives of Neuroscience · doi:10.5812/archneurosci.20078 · Cited by 177

Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s disease

Kontush, A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00688-8 · Cited by 178

Advances in the Understanding of Mammalian Copper Transporters

Wang, Y., Hodgkinson, V. L., Zhu, S., Weisman, G. A., & Petris, M. J. (2011) · Advances in Nutrition · doi:10.3945/an.110.000273 · Cited by 177

The Heterogeneous Nature of Cu 2+ Interactions with Alzheimer’s Amyloid-β Peptide

Drew, S. C., & Barnham, K. J. (2011) · Accounts of Chemical Research · doi:10.1021/ar200014u · Cited by 174

Mitochondria-targeted catalase reduces abnormal APP processing, amyloid production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension

Mao, P., Mańczak, M., Calkins, M. J., Truong, Q., Reddy, T. P., Reddy, A. P., Shirendeb, U. P., Lo, H., Rabinovitch, P. S., & Reddy, P. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds128 · Cited by 176

Site-Specific Interactions of Cu(II) with α and β-Synuclein: Bridging the Molecular Gap between Metal Binding and Aggregation

Binolfi, A., Lamberto, G. R., Durán, R., Quintanar, L., Bertoncini, C. W., Souza, J. M., Červeñanský, C., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803494v · Cited by 173

Mining literature for a comprehensive pathway analysis: A case study for retrieval of homocysteine related genes for genetic and epigenetic studies

Sharma, P., Senthilkumar, R., Brahmachari, V., Sundaramoorthy, E., Mahajan, A., Sharma, A., & Sengupta, S. (2006) · Lipids in Health and Disease · doi:10.1186/1476-511x-5-1 · Cited by 171

Fenton chemistry and oxidative stress mediate the toxicity of the β‐amyloid peptide in a Drosophila model of Alzheimer’s disease

Rival, T., Page, R. M., Chandraratna, D. S., Sendall, T. J., Ryder, E. J., Liu, B., Lewis, H. D., Rosahl, T. W., Hider, R. C., Camargo, L. M., et al. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06701.x · Cited by 171

The role of seladin‐1/DHCR24 in cholesterol biosynthesis, APP processing and Aβ generation in vivo

Crameri, A., Biondi, E., Kuehnle, K., Lütjohann, D., Thelen, K., Perga, S., Dotti, C. G., Nitsch, R. M., Ledesma, M. D., & Mohajeri, M. H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600938 · Cited by 170

BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease

Chami, L., & Checler, F. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-52 · Cited by 168

Cu and Zn coordination to amyloid peptides: From fascinating chemistry to debated pathological relevance

Atrián‐Blasco, E., Gonzalez, P., Santoro, A., Aliès, B., Faller, P., & Hureau, C. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.04.007 · Cited by 175

Excess of serum copper not related to ceruloplasmin in Alzheimer disease

Squitti, R., Pasqualetti, P., Forno, G. D., Moffa, F., Cassetta, E., Lupoi, D., Vernieri, F., Rossi, L. C., Baldassini, M., & Rossini, P. M. (2005) · Neurology · doi:10.1212/01.wnl.0000154531.79362.23 · Cited by 166

Copper Depletion Down-regulates Expression of the Alzheimer's Disease Amyloid-β Precursor Protein Gene

Bellingham, S. A., Lahiri, D. K., Maloney, B., Fontaine, S. L., Multhaup, G., & Camakaris, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400805200 · Cited by 165

Copper and prion disease

Brown, D. R. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00453-1 · Cited by 161

Localization of copper and copper transporters in the human brain

Davies, K. M., Hare, D. J., Cottam, V., Chen, N., Hilgers, L., Halliday, G. M., Mercer, J. F. B., & Double, K. L. (2012) · Metallomics · doi:10.1039/c2mt20151h · Cited by 163

Amyloid-β Peptide Disruption of Lipid Membranes and the Effect of Metal Ions

Lau, T., Ambroggio, E. E., Tew, D. J., Cappai, R., Masters, C. L., Fidelio, G. D., Barnham, K. J., & Separovic, F. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.091 · Cited by 162

Coenzyme Q10 Decreases Amyloid Pathology and Improves Behavior in a Transgenic Mouse Model of Alzheimer's Disease

Dumont, M., Kipiani, K., Yu, F., Wille, E. J., Katz, M., Calingasan, N. Y., Gouras, G. K., Lin, M. T. S., & Beal, M. F. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110209 · Cited by 164

Amyloid-β Binds Cu 2+ in a Mononuclear Metal Ion Binding Site

Karr, J. W., Kaupp, L. J., & Szalai, V. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0488028 · Cited by 160

Oxidative Stress and Cell Membranes in the Pathogenesis of Alzheimer's Disease

Axelsen, P. H., Komatsu, H., & Murray, I. V. J. (2011) · Physiology · doi:10.1152/physiol.00024.2010 · Cited by 159

Antioxidant Therapy in Alzheimers Disease: Theory and Practice

Aliev, G., Obrenovich, M. E., Reddy, V. P., Shenk, J. C., Moreira, P. I., Nunomura, A., Zhu, X., Smith, M. A., & Perry, G. L. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708786369582 · Cited by 160

Mitochondrial Dysfunction in Neurodegenerative Diseases Associated with Copper Imbalance

Rossi, L. C., Lombardo, M. F., Ciriolo, M. R., & Rotilio, G. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014820.99232.8a · Cited by 158

Synthesis, Characterization, and Metal Coordinating Ability of Multifunctional Carbohydrate-Containing Compounds for Alzheimer's Therapy

Storr, T., Merkel, M., Song-Zhao, G. X., Scott, L. E., Green, D. E., Bowen, M. L., Thompson, K. H., Patrick, B. O., Schugar, H. J., & Orvig, C. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068965r · Cited by 156

Genistein ameliorates β-amyloid peptide (25–35)-induced hippocampal neuronal apoptosis

Zeng, H., Chen, Q., & Zhao, B. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.10.018 · Cited by 157

Amyloid β‐protein (Aβ)1–40 protects neurons from damage induced by Aβ1–42 in culture and in rat brain

Zou, K., Kim, D. S., Kakio, A., Byun, K., Gong, J., Kim, J. W., Kim, M. J., Sawamura, N., Nishimoto, S., Matsuzaki, K., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02018.x · Cited by 160

Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid

Altschul, D., Launer, L. J., Adlard, P. A., Cherny, R. A., Tsatsanis, A., Volitakis, I., Blennow, K., Petrovitch, H., White, L. R., & Bush, A. I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.012 · Cited by 154

Pyrrolidine Dithiocarbamate Activates Akt and Improves Spatial Learning in APP/PS1 Mice without Affecting β-Amyloid Burden

Malm, T., Iivonen, H., Goldsteins, G., Keksa-Goldsteine, V., Ahtoniemi, T., Kanninen, K. M., Salminen, A., Auriola, S. O. K., van Groen, T., Tanila, H., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0059-07.2007 · Cited by 157

Liberation of Copper from Amyloid Plaques: Making a Risk Factor Useful for Alzheimer’s Disease Treatment

Geng, J., Li, M. C., Wu, L. J., Ren, J., & Qu, X. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003813 · Cited by 153

Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer’s amyloid β-peptide 1–42

Butterfield, D. A., & Kański, J. (2002) · Peptides · doi:10.1016/s0196-9781(02)00066-9 · Cited by 151

The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases

Rodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151

The oxidative stress hypothesis in Alzheimer's disease.

Pădurariu, M., Ciobica, A. S., Lefter, R. M., Șerban, I. L., Ștefănescu, C., & Chiriță, R. (2013) · PubMed · Cited by 155

Alzheimer’s disease: How metal ions define β-amyloid function

Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 154

Structural Studies of Copper(I) Complexes of Amyloid‐β Peptide Fragments: Formation of Two‐Coordinate Bis(histidine) Complexes

Himes, R. A., Park, G. Y., Siluvai, G. S., Blackburn, N. J., & Karlin, K. D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803908 · Cited by 148

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease

Unzeta, M., Esteban, G., Bolea, I., Fogel, W. A., Ramsay, R. R., Youdim, M. B. H., Tipton, K. F., & Marco, J. L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00205 · Cited by 154

Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease

Rogers, J. T., Bush, A. I., Cho, H.-H., Smith, D. H., Thomson, A. M., Friedlich, A. L., Lahiri, D. K., Leedman, P. J., Huang, X., & Cahill, C. M. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361282 · Cited by 148

Oxidative processes in Alzheimer's disease: the role of Aβ-metal interactions

Lynch, T. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00112-1 · Cited by 151

Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease

Cristóvão, J. S., Santos, R., & Gomes, C. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9812178 · Cited by 146

Probucol Increases Glutathione Peroxidase-1 Activity and Displays Long-Lasting Protection against Methylmercury Toxicity in Cerebellar Granule Cells

Farina, M., Campos, F., Vendrell, I., Berenguer, J., Barzi, M., Pons, S., & Sunol, C. E. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp219 · Cited by 144

Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease

Wang, L., Esteban, G., Ojima, M., Bautista‐Aguilera, Ó. M., Inokuchi, T., Moraleda, I., Iriepa, I., Samadi, A., Youdim, M. B. H., Romero, A., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.078 · Cited by 143

Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A amyloid pathway

Masters, C. L., & Beyreuther, K. (2006) · Brain · doi:10.1093/brain/awl251 · Cited by 145

d ‐penicillamine reduces serum oxidative stress in Alzheimer’s disease patients

Squitti, R., Rossini, P. M., Cassetta, E., Moffa, F., Pasqualetti, P., Cortesi, M., Colloca, A., Rossi, L. C., & Finazzi‐Agrò, A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00933.x · Cited by 142

Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities

Sbodio, J. I., Snyder, S. H., & Paul, B. D. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7321 · Cited by 149

Role of Hydrogen Peroxide in the Aetiology of Alzheimer??s Disease

Milton, N. G. N. (2004) · Drugs & Aging · doi:10.2165/00002512-200421020-00002 · Cited by 141

Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis

Dedeoglu, A., Cormier, K., Payton, S., Tseitlin, K. A., Kremsky, J. N., Lai, L., Li, X., Moir, R. D., Tanzi, R. E., Bush, A. I., et al. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.08.016 · Cited by 141

Why is the amyloid beta peptide of Alzheimer’s disease neurotoxic?

Rauk, A. (2008) · Dalton Transactions · doi:10.1039/b718601k · Cited by 139

Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses

Lee, H., Zhu, X., Castellani, R. J., Nunomura, A., Perry, G. L., & Smith, M. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.114009 · Cited by 142

Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration

Uddin, M. S., Mamun, A. A., Kabir, M. T., Ahmad, J., Jeandet, P., Sarwar, M. S., Ashraf, G. M., & Aleya, L. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173412 · Cited by 139

Structure and function of amyloid in Alzheimer's disease

Morgan, C., Colombres, M., Núñez, M. T., & Inestrosa, N. C. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.004 · Cited by 146

Structural and thermodynamical properties of CuII amyloid-β16/28 complexes associated with Alzheimer’s disease

Guilloreau, L., Damian, L., Coppel, Y., Mazarguil, H., Winterhalter, M., & Faller, P. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0154-1 · Cited by 134

Metal exposure and Alzheimer’s pathogenesis

Liu, G., Huang, W., Moir, R. D., Vanderburg, C. R., Lai, B. C. H., Peng, Z., Tanzi, R. E., Rogers, J. T., & Huang, X. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.12.011 · Cited by 135

Oxidative stress mediates the pathogenic effect of different Alzheimer’s disease risk factors

Guglielmotto, M. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.003.2010 · Cited by 135

Importance of dynamical processes in the coordination chemistry and redox conversion of copper amyloid-β complexes

Hureau, C., Balland, V., Coppel, Y., Solari, P. L., Fonda, E., & Faller, P. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0570-0 · Cited by 134

Alzheimer disease β-amyloid activity mimics cholesterol oxidase

Puglielli, L., Friedlich, A. L., Setchell, K. D. R., Nagano, S., Opazo, C., Cherny, R. A., Barnham, K. J., Wade, J. D., Melov, S., Kovacs, D. M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23610 · Cited by 134

The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders

Perry, G. L., Sayre, L. M., Atwood, C., Castellani, R. J., Cash, A., Rottkamp, C. A., & Smith, M. A. (2002) · CNS Drugs · doi:10.2165/00023210-200216050-00006 · Cited by 130

Biometals and Their Therapeutic Implications in Alzheimer's Disease

Ayton, S., Lei, P., & Bush, A. I. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0312-z · Cited by 134

Cu 2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo

Sheline, C. T., & Choi, D. W. (2004) · Annals of Neurology · doi:10.1002/ana.20047 · Cited by 129

Copper, β-amyloid, and Alzheimer's disease: Tapping a sensitive connection

Bush, A. I., Masters, C. L., & Tanzi, R. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135061100 · Cited by 128

Signal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer disease

Fuentealba, R. A., Farı́as, G. G., Scheu, J., Bronfman, M., Marzolo, M., & Inestrosa, N. C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.018 · Cited by 126

Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases

Breydo, L., & Uversky, V. N. (2011) · Metallomics · doi:10.1039/c1mt00106j · Cited by 129

Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease

Uddin, M. S., Kabir, M. T., Rahman, M. S., Behl, T., Jeandet, P., Ashraf, G. M., Najda, A., Bin-Jumah, M. N., El-Seedi, H. R., & Abdel‐Daim, M. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165858 · Cited by 131

Redox Reactions of the α-Synuclein−Cu2+ Complex and Their Effects on Neuronal Cell Viability

Wang, C., Liu, L., Zhang, L., Peng, Y., & Zhou, F. (2010) · Biochemistry · doi:10.1021/bi1010909 · Cited by 126

Alzheimer disease: Amyloidogenesis, the presenilins and animal models

Newman, M., Musgrave, I., & Lardelli, M. T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.12.001 · Cited by 129

BACE1 Cytoplasmic Domain Interacts with the Copper Chaperone for Superoxide Dismutase-1 and Binds Copper

Angeletti, B., Waldron, K. J., Freeman, K. B., Bawagan, H., Hussain, I., Miller, C. C. J., Lau, K., Tennant, M. E., Dennison, C., Robinson, N. J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412034200 · Cited by 126

Iron dysregulation in Huntington's disease

Müller, M., & Leavitt, B. R. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12739 · Cited by 123

Sequestration of Copper from β-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents

Wu, W., Lei, P., Liu, Q. R., Hu, J., Gunn, A. P., Chen, M., Rui, Y., Su, X., Xie, Z., Zhao, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804722200 · Cited by 124

Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration

Numakawa, T., Matsumoto, T., Numakawa, Y., Richards, M., Yamawaki, S., & Kunugi, H. (2011) · Journal of Toxicology · doi:10.1155/2011/405194 · Cited by 125

Cu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-β Peptides

Pedersen, J. T., Østergaard, J., Rozlosnik, N., Gammelgaard, B., & Heegaard, N. H. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220863 · Cited by 123

Metal ions influx is a double edged sword for the pathogenesis of Alzheimer’s disease

Wang, P., & Wang, Z. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.10.003 · Cited by 123

The galvanization of β-amyloid in Alzheimer's disease

Bush, A. I., & Tanzi, R. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122249699 · Cited by 122

Cu(II) Potentiation of Alzheimer Aβ1-40 Cytotoxicity and Transition on its Secondary Structure

Dai, X., Sun, Y., & Jiang, Z.-F. (2006) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2006.00228.x · Cited by 34

Copper and amyloid β: interactions in Alzheimer's disease

Yusof, M., & Sun, A. Y. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.81.s1.20_14.x · Cited by 1

Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical Relevance

Jiang, D., Men, L., Wang, J., Zhang, Y., Chickenyen, S., Wang, Y., & Zhou, F. (2007) · Biochemistry · doi:10.1021/bi700508n · Cited by 204

The Cu(II)/Aβ/Human Serum Albumin Model of Control Mechanism for Copper-Related Amyloid Neurotoxicity

Rózga, M., & Bal, W. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900358j · Cited by 54

Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid

Opazo, C., Huang, X., Cherny, R. A., Moir, R. D., Roher, A. E., White, A. R., Cappai, R., Masters, C. L., Tanzi, R. E., Inestrosa, N. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206428200 · Cited by 587